$7.21 Billion is the total value of C WorldWide Group Holding A/S's 171 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AMGN | AMGEN INC | $20,437,000 | +8.3% | 110,716 | 0.0% | 0.28% | -2.1% | |
AGN | ALLERGAN PLC | $14,188,000 | -0.9% | 85,101 | 0.0% | 0.20% | -10.5% | |
BIIB | BIOGEN INC | $14,102,000 | +6.0% | 48,586 | 0.0% | 0.20% | -3.9% | |
EW | EDWARDS LIFESCIENCES CORP | $13,450,000 | +4.3% | 92,393 | 0.0% | 0.19% | -5.6% | |
ABBV | ABBVIE INC | $13,274,000 | -2.1% | 143,271 | 0.0% | 0.18% | -11.5% | |
BDX | BECTON DICKINSON & CO | $12,686,000 | +10.6% | 52,955 | 0.0% | 0.18% | 0.0% | |
BSX | BOSTON SCIENTIFIC CORP | $12,007,000 | +19.7% | 367,194 | 0.0% | 0.17% | +8.4% | |
CNC | CENTENE CORP DEL | $11,539,000 | +15.3% | 93,653 | 0.0% | 0.16% | +3.9% | |
ALXN | ALEXION PHARMACEUTICALS INC | $9,383,000 | +11.4% | 75,574 | 0.0% | 0.13% | +0.8% | |
ESRX | EXPRESS SCRIPTS HLDG CO | $9,235,000 | +11.8% | 119,604 | 0.0% | 0.13% | +0.8% | |
JAZZ | JAZZ PHARMACEUTICALS PLC | $8,545,000 | +14.1% | 49,592 | 0.0% | 0.12% | +3.5% | |
HCA | HCA HEALTHCARE INC | $8,160,000 | +5.8% | 79,535 | 0.0% | 0.11% | -4.2% | |
CI | CIGNA CORPORATION | $6,241,000 | +1.3% | 36,723 | 0.0% | 0.09% | -8.4% | |
BMRN | BIOMARIN PHARMACEUTICAL INC | $5,323,000 | +16.2% | 56,512 | 0.0% | 0.07% | +5.7% | |
HOLX | HOLOGIC INC | $3,533,000 | +6.4% | 88,877 | 0.0% | 0.05% | -3.9% | |
AQN | ALGONQUIN PWR UTILS CORP | $2,133,000 | -0.5% | 167,900 | 0.0% | 0.03% | -9.1% | |
STOR | STORE CAP CORP | $1,380,000 | +10.4% | 50,360 | 0.0% | 0.02% | 0.0% | |
WBA | WALGREENS BOOTS ALLIANCE INC | $1,137,000 | -8.3% | 18,947 | 0.0% | 0.02% | -15.8% | |
GOOGL | ALPHABET INCcap stk cl a | $981,000 | +8.9% | 869 | 0.0% | 0.01% | 0.0% | |
BLUE | BLUEBIRD BIO INC | $329,000 | -8.1% | 2,098 | 0.0% | 0.01% | 0.0% | |
AGIO | AGIOS PHARMACEUTICALS INC | $261,000 | +2.8% | 3,102 | 0.0% | 0.00% | 0.0% | |
KPTI | KARYOPHARM THERAPEUTICS INC | $265,000 | +26.2% | 15,612 | 0.0% | 0.00% | +33.3% | |
XLRN | ACCELERON PHARMA INC | $220,000 | +24.3% | 4,537 | 0.0% | 0.00% | 0.0% | |
IONS | IONIS PHARMACEUTICALS INC | $187,000 | -5.6% | 4,483 | 0.0% | 0.00% | 0.0% | |
RDUS | RADIUS HEALTH INC | $185,000 | -18.1% | 6,279 | 0.0% | 0.00% | 0.0% | |
LXRX | LEXICON PHARMACEUTICALS INC | $166,000 | +40.7% | 13,813 | 0.0% | 0.00% | 0.0% | |
ESPR | ESPERION THERAPEUTICS INC NE | $169,000 | -45.7% | 4,304 | 0.0% | 0.00% | -60.0% | |
SNDX | SYNDAX PHARMACEUTICALS INC | $78,000 | -50.9% | 11,153 | 0.0% | 0.00% | -50.0% | |
ACAD | ACADIA PHARMACEUTICALS INC | $107,000 | -32.3% | 7,032 | 0.0% | 0.00% | -50.0% | |
ICPT | INTERCEPT PHARMACEUTICALS IN | $104,000 | +35.1% | 1,244 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-03
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VISA INC | 37 | Q3 2023 | 15.5% |
THERMO FISHER SCIENTIFIC INC | 37 | Q3 2023 | 11.2% |
HDFC BANK LTD | 37 | Q3 2023 | 3.7% |
ICICI BK LTD | 37 | Q3 2023 | 2.1% |
CENTENE CORP DEL | 37 | Q3 2023 | 0.4% |
DEX INC | 37 | Q3 2023 | 0.5% |
BIOMARIN PHARMACEUTICAL INC | 37 | Q3 2023 | 0.3% |
VERTEX PHARMACEUTICALS INC | 37 | Q3 2023 | 0.4% |
INSULET CORP | 37 | Q3 2023 | 0.3% |
CARA THERAPEUTICS INC | 37 | Q3 2023 | 0.2% |
View C WorldWide Group Holding A/S's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-03 |
13F-HR | 2024-02-05 |
13F-HR | 2023-11-03 |
13F-HR | 2023-08-02 |
13F-HR | 2023-05-02 |
13F-HR | 2023-02-03 |
13F-HR | 2022-11-03 |
13F-HR | 2022-08-02 |
13F-HR | 2022-05-04 |
13F-HR | 2022-02-02 |
View C WorldWide Group Holding A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.